Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054) : A PARALLEL, DOUBLE-BLIND, MULTICENTER, WORLDWIDE STUDY TO EVALUATE THE TOLERABILITY OF MK-0524A AGAINST PROLONGED RELEASE NIACINE

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 05. Juni Zur Gesamtaufnahme - year:2023

Sprache:

Latein

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: -R232 Flushing Flushing;R232;Flushing
Phase: Phase 3
Recruitment Status: Completed
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 25-09-2006, Last updated: 2023-06-22

ICTRP ID:

PER-074-06
NA
NCT00378833

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO004624556